In 2008, The Tisch Cancer Institute (TCI) was established through the generosity of James S. and Merryl Tisch. The founding of The Tisch Cancer Institute allowed for critical faculty recruits, including TCI’s inaugural Director, Steven Burakoff, MD. Mount Sinai’s commitment to cancer research and Dr. Burakoff’s vision to create the infrastructure, reporting mechanisms, and shared resources were critical for The Tisch Cancer Institute’s new National Cancer Institute (NCI) designation.
The 2012 opening of the Leon and Norma Hess Center for Science and Medicine on The Mount Sinai Hospital campus created additional research space and facilitated real-time collaboration between physicians, investigators, and specialists from across disciplines. The Hess Center houses the Derald H. Ruttenberg Treatment Center of The Tisch Cancer Institute, a 50,000-square-foot comprehensive treatment center for patients, which includes 48 exam rooms on the third floor, 54 state-of-the-art chemotherapy infusion suites on the fourth floor, and a patient resource center. The Hess Center also houses Radiation Oncology and Cancer Imaging. In addition, the Dubin Breast Center, established through a generous gift by Mount Sinai Trustees Glenn Dubin and Eva Andersson-Dubin, MD, provides a multidisciplinary approach to breast cancer screening, treatment, and survivorship in a 15,000-square-foot facility in The Mount Sinai Hospital.
Mount Sinai’s commitment to cancer research has allowed TCI to develop the infrastructure, reporting mechanisms, programs, and shared resources critical for the establishment of a 2015 NCI-designated cancer center.
The Tisch Cancer Institute is a vital component of the Icahn School of Medicine at Mount Sinai and plays a key role in the Mount Sinai Health System, which is one of the largest health care systems in the nation.